Source:http://linkedlifedata.com/resource/pubmed/id/10943610
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2000-8-29
|
pubmed:abstractText |
To analyze the recent change in the long-term survival of patients with dilated cardiomyopathy (DCM), the present study comprised consecutive 111 patients with ejection fraction <50% and left ventricular end-diastolic diameter >58 mm. who were admitted to hospital from January 1983 to December 1994. The patients were divided into 2 groups: group A who were diagnosed before 1989 and group B diagnosed after 1990. Basic characteristics at diagnosis, including age, NYHA functional class, left ventricular end-diastolic diameter and ejection fraction, were similar between these 2 groups. Calculated survival rate at 5 years was 90.0% in group B in contrast to 62.3% in group A. Event-free survival also improved in group B. In group B, beta-blockers and angiotensin converting enzyme inhibitors were more frequently used than in group A (p<0.0001) whereas digitalis and other positive inotropic agents were significantly less used. Left ventricular ejection fraction was significantly improved during the follow-up period in patients treated with beta-blockers compared with those not treated with beta-blockers. These data indicate a significant improvement in the survival of patients with dilated cardiomyopathy after 1990, which may be explained by the change of medical treatment, especially the use of beta-blockers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0047-1828
|
pubmed:author |
pubmed-author:AzumaAA,
pubmed-author:HirasakiSS,
pubmed-author:HirataAA,
pubmed-author:HyogoMM,
pubmed-author:KawasakiTT,
pubmed-author:KunishigeHH,
pubmed-author:KuribayashiTT,
pubmed-author:MatsuoAA,
pubmed-author:NakagawaMM,
pubmed-author:NakamuraTT,
pubmed-author:ShimaTT,
pubmed-author:SugiharaHH,
pubmed-author:YamamotoKK
|
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
333-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10943610-Adrenergic beta-Antagonists,
pubmed-meshheading:10943610-Adult,
pubmed-meshheading:10943610-Aged,
pubmed-meshheading:10943610-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:10943610-Cardiomyopathy, Dilated,
pubmed-meshheading:10943610-Female,
pubmed-meshheading:10943610-Humans,
pubmed-meshheading:10943610-Male,
pubmed-meshheading:10943610-Middle Aged,
pubmed-meshheading:10943610-Prognosis,
pubmed-meshheading:10943610-Survival Analysis,
pubmed-meshheading:10943610-Ventricular Function, Left
|
pubmed:year |
1999
|
pubmed:articleTitle |
Improved survival of idiopathic dilated cardiomyopathy in the 1990s.
|
pubmed:affiliation |
Second Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|